International safety notice
Ensayos Atellica CH: LDL Cholesterol Direct. UDI: 00630414596181, Total Protein II. UDI: 00630414596372, Triglycerides (concentrado). UDI: 00630414596495, Triglycerides 2. UDI: 00630414610955
Spain / AEMPS · ESP · Feb 14, 2023
Key facts
| Title | Ensayos Atellica CH: LDL Cholesterol Direct. UDI: 00630414596181, Total Protein II. UDI: 00630414596372, Triglycerides (concentrado). UDI: 00630414596495, Triglycerides 2. UDI: 00630414610955 |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | Ensayos Atellica CH: LDL Cholesterol Direct. UDI: 00630414596181, Total Protein II. UDI: 00630414596372, Triglycerides (concentrado). UDI: 00630414596495, Triglycerides 2. UDI: 00630414610955 |
| Manufacturer | Siemens Healthcare Diagnostics Inc. EEUU. |
| Models | 11097604, 11097632, 2023-054, V1.27, 00630414596495TRIGLYCERIDES_2, 11537222, 00630414610955, 90192, 00630414596181TOTAL, 28022, 28906, 00630414596181 and 7 more |
| Event type | Safety Notice |
| Date | Feb 14, 2023 |
At a glance
- No Recall
- Yes Field safety notice
- 1–9 Matching device models in FDA data
- 1–9 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1